Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

206

Full text

173

Free full text

83

Publication Types

Journal Article

207

Research Support, Non-U.S. Gov't

100

Review

50

Clinical Trial

32

Randomized Controlled Trial

25

Clinical Trial, Phase II

24

Research Support, N.I.H., Extramural

24

Multicenter Study

21

Clinical Trial, Phase I

20

Meta-Analysis

12

Research Support, U.S. Gov't, P.H.S.

9

Comparative Study

6

Systematic Review

5

Observational Study

5

Research Support, U.S. Gov't, Non-P.H.S.

4

Clinical Trial Protocol

3

Clinical Trial, Phase III

2

Validation Study

2

Research Support, N.I.H., Intramural

1

Twin Study

1

News

1

Equivalence Trial

1

Publication Year

From

To

Quick links

Individual year

2025

4

2024

5

2023

2

2022

7

2021

10

2020

12

2019

11

2018

4

2017

9

2016

11

2015

10

2014

15

2013

12

2012

14

2011

10

2010

8

2009

15

2008

6

2007

10

2006

10

2005

9

2004

4

2003

2

2002

2

2001

5

2000

3

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Glucuronosyltransferase""[mesh_terms]

210 Results

Searching titles within these results

Diagnostic criteria and contributors to Gilbert's syndrome.

Karl-Heinz Wagner, Ryan G Shiels, Claudia Anna Lang, Nazlisadat Seyed Khoei, Andrew C Bulmer

Critical reviews in clinical laboratory sciences 2019;55(2):129-139

Human UDP-glucuronosyltransferases: feedback loops between substrates and ligands of their transcription factors.

Karl Walter Bock

Biochemical pharmacology 2012;84(8):1000-6

Per- and polyfluoroalkyl substances display structure-dependent inhibition towards UDP-glucuronosyltransferases.

Yong-Zhe Liu, Zhi-Peng Zhang, Zhi-Wei Fu, Kun Yang, Ning Ding, Li-Gang Hu, Zhong-Ze Fang, Xiaozhen Zhuo

Environmental pollution (Barking, Essex : 1987) 2019;254(Pt B):113093

UGT1AI6 and UGT1A127 for individualized irinotecan chemotherapy.

Yuichi Ando, Ken-Ichi Fujita, Yasutsuna Sasaki, Yoshinori Hasegawa

Current opinion in molecular therapeutics 2007;9(3):258-62

Induction of UDP-glucuronosyltransferase by the flavonoids chrysin and quercetin in Caco-2 cells.

A Galijatovic, U K Walle, T Walle

Pharmaceutical research 2000;17(1):21-6

UGT1A1*6 polymorphisms are correlated with irinotecan-induced toxicity: a system review and meta-analysis in Asians.

Lei Cheng, Ming Li, Jing Hu, Wei Ren, Li Xie, Zhan-Peng Sun, Bao-Rui Liu, Gen-Xing Xu, Xiao-Liang Dong, Xiao-Ping Qian

Cancer chemotherapy and pharmacology 2014;73(3):551-60

Pharmacogenetics of irinotecan disposition and toxicity: a review.

Alex Sparreboom, Ken-ichi Fujita

Current clinical pharmacology 2010;5(3):209-17

A new frame-shifting mutation of UGT1A1 gene causes type I Crigler-Najjar syndrome.

Jin Wang, Ling-Juan Fang, Long Li, Jian-She Wang, Chao Chen

Chinese medical journal 2012;124(23):4109-11

Predictive role of the UGT1A1, UGT1A7, and UGT1A9 genetic variants and their haplotypes on the outcome of metastatic colorectal cancer patients treated with fluorouracil, leucovorin, and irinotecan.

Giuseppe Toffoli, Federico Innocenti, Mario D'Andrea, Elena De Mattia, Angela Buonadonna, Giuseppe Corona, Paola Biason, Erika Cecchin

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(15):2457-65

The influence of UGT polymorphisms as biomarkers in solid organ transplantation.

Federico Innocenti, Robert Dupuis, Andrea Yuen

Clinica chimica acta; international journal of clinical chemistry 2013;413(17-18):1318-25

Pharmacogenetic approach for cancer treatment-tailored medicine in practice.

Yoshinori Hasegawa, Yuichi Ando, Maki Ando, Naozumi Hashimoto, Kazuyoshi Imaizumi, Kaoru Shimokata

Annals of the New York Academy of Sciences 2007;1086():223-32

Human UDP-glucuronosyltransferases: metabolism, expression, and disease.

C P Strassburg, R H Tukey

Annual review of pharmacology and toxicology 2000;40():581-616

Inhibition of UDP-glucuronosyltransferases (UGTs) by polycyclic aromatic hydrocarbons (PAHs) and hydroxy-PAHs (OH-PAHs).

Zhong-Ze Fang, Dafang Zhang, Weihua Zhu, Ruo-Yong Jia, Guo-Qiang Qin, Qiaoyun Yang, Yu Bai

Environmental pollution (Barking, Essex : 1987) 2020;263(Pt B):114521

Efficacy and safety of high doses of irinotecan in patients with metastatic colorectal cancer treated with the FOLFIRI regimen based on the UGT1A1 genotype: A systematic review.

Marta Miarons, Pau Riera, Sara García-Gil, Fernando Gutiérrez-Nicolás

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 2022;46(4):224-233

Association of UGT1A16, UGT1A128, or ABCC2 c.3972C>T genetic polymorphisms with irinotecan-induced toxicity in Asian cancer patients: Meta-analysis.

Chonlaphat Sukasem, Natchaya Vanwong, Yaowaluck Hongkaew, Jiratha Rachanakul, Nutthan Nuntharadthanaphong, Pimonpan Jinda, Mohitosh Biswas, Chalirmporn Atasilp, Surasak Saokaew

Clinical and translational science 2022;15(7):1613-1633

Results: 1 – 15 / 210

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.